Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis
Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to assess the efficacy and safety of loading doses versus
standard dose of intravenous Bondronat in reducing pain in patients with lung cancer and bone
metastatic disease.